Raven Biotechnologies news from FierceVaccines
News
VaxGen faces possible liquidation after merger flops
The spectacularly unsuccessful VaxGen has called off an effort to Read more...
Get more Raven Biotechnologies coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets